
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6493418
[patent_doc_number] => 20100209420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF P13K ALPHA'
[patent_app_type] => utility
[patent_app_number] => 12/595219
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 104040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209420.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595219 | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha | Apr 8, 2008 | Issued |
Array
(
[id] => 5585010
[patent_doc_number] => 20090104212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS USING TWO-PHOTON SIMULTANEOUS ABSORPTION'
[patent_app_type] => utility
[patent_app_number] => 12/059484
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19419
[patent_no_of_claims] => 191
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104212.pdf
[firstpage_image] =>[orig_patent_app_number] => 12059484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/059484 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS USING TWO-PHOTON SIMULTANEOUS ABSORPTION | Mar 30, 2008 | Abandoned |
Array
(
[id] => 4753294
[patent_doc_number] => 20080161369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'EPOTHILONE DERIVATIVE FOR THE TREATMENT OF HEPATOMA AND OTHER CANCER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/046017
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5622
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12046017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/046017 | EPOTHILONE DERIVATIVE FOR THE TREATMENT OF HEPATOMA AND OTHER CANCER DISEASES | Mar 10, 2008 | Abandoned |
Array
(
[id] => 4839279
[patent_doc_number] => 20080279764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'METHOD AND COMPOSITION FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/044761
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5179
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279764.pdf
[firstpage_image] =>[orig_patent_app_number] => 12044761
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/044761 | METHOD AND COMPOSITION FOR TREATING CANCER | Mar 6, 2008 | Abandoned |
Array
(
[id] => 6352987
[patent_doc_number] => 20100086518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'TREATMENT OF MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 12/530231
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17833
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086518.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530231 | TREATMENT OF MELANOMA | Mar 6, 2008 | Abandoned |
Array
(
[id] => 4820409
[patent_doc_number] => 20080226624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect'
[patent_app_type] => utility
[patent_app_number] => 12/073693
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 5751
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12073693
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/073693 | Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect | Mar 6, 2008 | Abandoned |
Array
(
[id] => 6356033
[patent_doc_number] => 20100086931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING DECREASE IN GENE EXPRESSION LEVEL AS INDEX'
[patent_app_type] => utility
[patent_app_number] => 12/529971
[patent_app_country] => US
[patent_app_date] => 2008-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19783
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086931.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529971
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529971 | METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING DECREASE IN GENE EXPRESSION LEVEL AS INDEX | Mar 4, 2008 | Abandoned |
Array
(
[id] => 5386388
[patent_doc_number] => 20090227633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Methods to inhibit tumor cell growth by using proton pump inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/074644
[patent_app_country] => US
[patent_app_date] => 2008-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 7345
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227633.pdf
[firstpage_image] =>[orig_patent_app_number] => 12074644
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/074644 | Methods to inhibit tumor cell growth by using proton pump inhibitors | Mar 3, 2008 | Abandoned |
Array
(
[id] => 4728218
[patent_doc_number] => 20080207762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'METHOD OF TREATING INFLAMMATORY ACNE VULGARIS WITH CARBAMIDE PEROXIDE'
[patent_app_type] => utility
[patent_app_number] => 12/036901
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 842
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207762.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036901
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036901 | METHOD OF TREATING INFLAMMATORY ACNE VULGARIS WITH CARBAMIDE PEROXIDE | Feb 24, 2008 | Abandoned |
Array
(
[id] => 6433386
[patent_doc_number] => 20100152298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => ' Present invention relates to a treatment for the management of cancer more specially the use of Flutamide anti-androgen drugsa'
[patent_app_type] => utility
[patent_app_number] => 12/029473
[patent_app_country] => US
[patent_app_date] => 2008-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1819
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152298.pdf
[firstpage_image] =>[orig_patent_app_number] => 12029473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/029473 | Present invention relates to a treatment for the management of cancer more specially the use of Flutamide anti-androgen drugsa | Feb 11, 2008 | Abandoned |
Array
(
[id] => 4477367
[patent_doc_number] => 07906486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa'
[patent_app_type] => utility
[patent_app_number] => 12/526585
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25352
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526585
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526585 | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa | Feb 10, 2008 | Issued |
Array
(
[id] => 8082111
[patent_doc_number] => 08148377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile'
[patent_app_type] => utility
[patent_app_number] => 12/069667
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10034
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069667 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Feb 10, 2008 | Issued |
Array
(
[id] => 4728096
[patent_doc_number] => 20080207640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Method of treating cell proliferative disorders using growth hormone secretagogues'
[patent_app_type] => utility
[patent_app_number] => 12/069533
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11749
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069533 | Method of treating cell proliferative disorders using growth hormone secretagogues | Feb 10, 2008 | Abandoned |
Array
(
[id] => 9778028
[patent_doc_number] => 08853233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/526225
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2363
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12526225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526225 | Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives | Feb 6, 2008 | Issued |
Array
(
[id] => 4514966
[patent_doc_number] => 07910580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Enhancement of effectiveness of 5-Fluorouracil in treatment of tumor metastases and cancer'
[patent_app_type] => utility
[patent_app_number] => 12/016294
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1336
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12016294
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/016294 | Enhancement of effectiveness of 5-Fluorouracil in treatment of tumor metastases and cancer | Jan 17, 2008 | Issued |
Array
(
[id] => 8896799
[patent_doc_number] => 08476320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones'
[patent_app_type] => utility
[patent_app_number] => 12/523305
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17587
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523305 | Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones | Jan 15, 2008 | Issued |
Array
(
[id] => 5297179
[patent_doc_number] => 20090012105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Combination of Mtor Inhibitor and Antipolate Compound'
[patent_app_type] => utility
[patent_app_number] => 12/087385
[patent_app_country] => US
[patent_app_date] => 2008-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12693
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12087385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/087385 | Combination of Mtor Inhibitor and Antipolate Compound | Jan 11, 2008 | Abandoned |
Array
(
[id] => 4609602
[patent_doc_number] => 07994216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Stage-specific reduction of LUTS in prostate disease'
[patent_app_type] => utility
[patent_app_number] => 11/972892
[patent_app_country] => US
[patent_app_date] => 2008-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3269
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/994/07994216.pdf
[firstpage_image] =>[orig_patent_app_number] => 11972892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/972892 | Stage-specific reduction of LUTS in prostate disease | Jan 10, 2008 | Issued |
Array
(
[id] => 6537937
[patent_doc_number] => 20100204263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'METHOD OF TREATING MULTIDRUG RESISTANT CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/522463
[patent_app_country] => US
[patent_app_date] => 2008-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 12919
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522463 | METHOD OF TREATING MULTIDRUG RESISTANT CANCERS | Jan 8, 2008 | Abandoned |
Array
(
[id] => 6492429
[patent_doc_number] => 20100093610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'ROMIDEPSIN-BASED TREATMENTS FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/521392
[patent_app_country] => US
[patent_app_date] => 2007-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12522
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12521392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521392 | ROMIDEPSIN-BASED TREATMENTS FOR CANCER | Dec 27, 2007 | Abandoned |